patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · small molecule
imatinib mesylate
Phase 2updated 2mo agoby $IKT Inhibikase Therapeutics, Inc.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for chronic myelogenous leukemia and 55 investigational indications.
targets
Bcr/Abl fusion proteinMast/stem cell growth factor receptor KitPlatelet-derived growth factor receptor betaTyrosine-protein kinase ABL1
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that